- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Embecta (NASDAQ:EMBC), Quotes and News Summary
Embecta (NASDAQ: EMBC)
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-08 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.870 | (EXPECTED) 2022-08-15 | |||||
| REV | 276.860M | ||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Embecta Questions & Answers
You can purchase shares of Embecta (NASDAQ: EMBC) through any online brokerage.
Other companies in Embecta’s space includes: RxSight (NASDAQ:RXST), Meridian Bioscience (NASDAQ:VIVO), BioLife Solns (NASDAQ:BLFS), Align Tech (NASDAQ:ALGN) and ICU Medical (NASDAQ:ICUI).
The latest price target for Embecta (NASDAQ: EMBC) was reported by Morgan Stanley on Monday, August 1, 2022. The analyst firm set a price target for 33.00 expecting EMBC to rise to within 12 months (a possible 9.96% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Embecta (NASDAQ: EMBC) is $30.01 last updated Today at August 10, 2022, 8:00 PM UTC.
There are no upcoming dividends for Embecta.
Embecta’s Q4 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for Embecta.
Embecta is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.